OC
RDY icon

Oppenheimer & Co’s Dr. Reddy's Laboratories RDY Stock Holding History

Oppenheimer & Co’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-16,975
Closed -$217K – 1352
2015
Q3 		$217K Sell
16,975
-3,775
-18% -$46.9K 0.01% 1133
2015
Q2 		$230K Sell
20,750
-2,925
-12% -$32.3K 0.01% 1219
2015
Q1 		$270K Sell
23,675
-500
-2% -$5.3K 0.01% 1144
2014
Q4 		$244K Hold
24,175
– – 0.01% 1117
2014
Q3 		$254K Hold
24,175
– – 0.01% 1148
2014
Q2 		$209K Hold
24,175
– – 0.01% 1241
2014
Q1 		$212K Buy
+24,175
New +$210K 0.01% 1212

Other funds holding RDY

Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VAM
Vontobel Asset Management New York $18.1B AUM 28.09% 1-Year Est. Return
BG
BlackRock Group London, United Kingdom $210B AUM 15.5% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Oppenheimer & Co's RDY Position: Q4 2015 in Review

Oppenheimer & Co sold out of Dr. Reddy's Laboratories (RDY) in Q4 2015, closing a stake of 16,975 shares — an estimated $217K sold.

Oppenheimer & Co first reported a position in RDY in Q1 2014 and held it in 7 quarters. The position peaked at $270K in Q1 2015. 174 funds tracked by Wall St. Rank hold RDY as of Q4 2015.

  • Oppenheimer & Co reported no remaining Dr. Reddy's Laboratories position as of Q4 2015 after selling out during the quarter.
  • Oppenheimer & Co sold 16,975 Dr. Reddy's Laboratories shares in Q4 2015, an estimated $217K.
  • Oppenheimer & Co first reported a position in Dr. Reddy's Laboratories in Q1 2014 and held it in 7 quarters.
  • Oppenheimer & Co's Dr. Reddy's Laboratories position peaked at $270K in Q1 2015.
  • 174 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q4 2015.

Based on Oppenheimer & Co's 13F filing for Q4 2015, filed 3 Feb 2016.